AbCellera (ABCL) stock rose 6% after Q2 earnings and announcement of Phase 2 data for non-hormonal menopause treatment ABCL635 coming August 10, 2026. The post AbCellera (ABCL) Stock Surges 6% on Menopause Treatment Phase 2 Data Reveal appeared first on Blockonomi.